Back to AXSMView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Fibromyalgia
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
AXS-12 (reboxetine)Phase 3
Narcolepsy
Solriamfetol 150 mgPhase 3
Excessive Sleepiness
AXS-05 (dextromethorphan and bupropion) oral tabletsPhase 3
Major Depressive Disorder
Solriamfetol 300 mgPhase 3
Binge-Eating Disorder
AXS-05Phase 3
Agitation in Patients With Dementia of the Alzheimer's Type
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts